Skip to search formSkip to main content

PCH Regimen

Known as: Paclitaxel-Carboplatin-Herceptin Regimen 
A sequential regimen consisting of carboplatin and paclitaxel, followed by trastuzumab, used in the adjuvant setting for the treatment of HER-2/neu… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare causes of pulmonary… Expand
Is this relevant?
Review
2018
Review
2018
Pulmonary veno-occlusive disease (PVOD)/pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary vascular disease… Expand
Is this relevant?
2018
2018
Objective: To improve the diagnosis and treatment of the pulmonary veno-occlusive disease (PVOD) and pulmonary capillary… Expand
Is this relevant?
2013
2013
Plasma cell hepatitis (PCH), also known as "de novo autoimmune" hepatitis, is an increasingly recognized, but suboptimally named… Expand
  • figure 1
  • table 2
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2011
2011
The current paper seeks to describe a small-scale hydro-energetic resources assessment method as a function of social and… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2010
Review
2010
Monoclonal antibodies (mAbs) have demonstrated considerable utility in the clinical treatment of cancer (Reichert et al. 2005… Expand
Is this relevant?
2009
2009
IntroductionHER2 overexpression, or rather HER2 gene amplification, is indicative for Herceptin therapy in both metastatic and… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2006
Review
2006
Trastuzumab (Herceptin®) is a humanized monoclonal antibody used in the treatment of breast cancer that overexpresses human… Expand
Is this relevant?
2002
2002
HER2-positive status is the sole criterion for identifying patients with breast cancer for Herceptin® therapy, which has known… Expand
Is this relevant?